VisionSys AI Inc Annual Report - How They Did This Year

I’ve put together this guide to help you understand how VisionSys AI Inc performed this year. My goal is to cut through the corporate jargon and help you decide if this company is a good fit for your portfolio.

1. What does this company do?

VisionSys AI Inc (formerly Tarena International) has completely reinvented itself. They have exited the education business to become a dedicated AI company focused on Brain-Computer Interface (BCI) technology. They now research and build the software and hardware needed to connect human brain activity to digital systems.

The company completed a "clean break" from its past. After selling their professional education business in 2024, they offloaded their remaining STEM assets in August 2025 for $1. They are now operating as a new entity, having shed all their previous operations to focus entirely on this new AI direction.

2. Financial performance: The bottom line

Because the company spent two years selling off its main businesses, the financial history is in transition. They reported zero revenue from their core business in 2023 and 2024. While they reported revenue in 2025, it reflects their new, unproven AI focus rather than a history of sales.

You should view this as a startup phase. The company is moving from a service-based model to a costly research-and-development model, where current sales are small compared to the significant costs of building their new technology.

3. Major wins and challenges

• The Big Win: They successfully finished "Disposition 2025," fully shedding their old education businesses. They are now lean and focused entirely on BCI technology, removing the weight of their former operations.
• The Challenge: They are a Cayman Islands holding company with operations in China. They are starting from scratch in a difficult, expensive industry, competing against tech giants and well-funded research labs.

4. Financial health: Can they pay the bills?

The company is in a fragile, early-stage position. As a holding company, they rely on their subsidiaries to generate cash. If they need to move money from China to the parent company to pay debts, they face regulatory hurdles. There is no guarantee that cash earned in China will be available to investors or for use outside the country, as strict foreign exchange rules apply.

5. Key risks: What could go wrong?

• Regulatory "Red Tape": Operating in China while listed on the NASDAQ is complex. Chinese rules regarding data and overseas listings change often. If they fall out of favor with regulators, their ability to operate is at risk, especially since BCI technology involves sensitive neural data.
• The "Startup" Gamble: You aren't buying a company with steady profits; you are betting on their ability to build BCI technology. If their tech fails, or they run out of cash, there is no safety net.
• Limited Access to Cash: Because of their structure, they may struggle to move money across borders. The parent company’s ability to pay depends entirely on its Chinese subsidiaries, which is not guaranteed.

6. Future outlook

VisionSys is now a startup in the BCI space. Their future depends entirely on their ability to build and sell AI-driven brain-computer products. They have no track record here, making this a highly speculative investment. Success requires turning research into commercial products, which remains unproven.

Investor Takeaway: If you are considering an investment, ask yourself if you are comfortable with "startup-level" risk. This is no longer the education company it once was; it is a high-stakes bet on emerging BCI technology. Because the company is essentially starting from zero, your investment is tied directly to their ability to successfully develop and commercialize a product that does not yet have a proven market.